During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a Qualified Institutions Placement (QIP) to raise up to Rs. 4,500...
Pharma stock that offers generic formulations and API products, including anti-diabetics, immunosuppressants, and many more in focus after receiving US FDA’s approval for Key Cancer drugs. Price Movement With a market capitalization of ₹38,251 Crores the shares of...
This leading pharma company stock is in focus after its drug, YESINTEK has been approved by the European Commission for marketing in the European Union region. Share Price Movement With a market capitalization of Rs. 40,322 Crore, the stock of Biocon opened at Rs....
One of the pharmaceutical stocks engaged in the manufacturing of biotechnology products and research services. The stock is in focus after receiving approval from China’s National Medical Products Administration (NMPA) for Tacrolimus capsules Stock Price...
When stocks surpass their 200-day moving averages, it often signals a potent bullish momentum shift and improved long-term market sentiment. This technical breakthrough can indicate sustained upward trends, particularly significant in the current market landscape...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
